KB

Kanchan Barnwal

Active Director Director DIN 08394780
DIN 08394780 First appointment Mar 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value •••• Premium profile

About Kanchan Barnwal

Data last updated:

Kanchan Barnwal is a Director at Blitzen Pharma Private Limited (since 2019). The company operates in Trading. Blitzen Pharma Private Limited reported revenue of ₹8.8 Lakh (FY 2024).

DIN 08394780
Primary Designation Director
Industry Trading
First Appointment 19 Mar 2019
Oldest Company Age 7 yrs
Largest company Blitzen Pharma Private Limited · ₹8.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Blitzen Pharma Private Limited U51909UP2019PTC114861
Director19 Mar 20192019₹8.8 Lakh (FY 2024)Active

Board colleagues of Kanchan Barnwal

NameDINCompanyDesignation
Anil Kumar Barnwal08394779Blitzen Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Blitzen Pharma Private Limited
Premium access

Shareholding and investment profile for Kanchan Barnwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanchan Barnwal

Kanchan Barnwal currently holds 1 directorship: Blitzen Pharma Private Limited (Director, since 19 Mar 2019, revenue ₹8.8 Lakh (FY 2024)).

Kanchan Barnwal was first appointed on 19 Mar 2019 as Director at Blitzen Pharma Private Limited.

The current boards of Kanchan Barnwal's companies include Anil Kumar Barnwal (Blitzen Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available